Philps FAST2022 picoSAT Pulse Oximetry Desaturation Study
Completed · NCT05683366
Conditions: SpO2 (Peripheral Oxygen Saturation) Measurement Validation
At a glance
- Research payments reported, 2025
- $20,790
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 72
About the trial
- Sponsor
- Philips Clinical & Medical Affairs Global
- Tested
- No Intervention (device)
- Dates
- Started 2022-12-13; completion 2023-09-07
- Results posted
- Not yet
Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.
From ClinicalTrials.gov, last updated 2024-04-03. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $20,790 in research payments for this study in 2025 (1 payments).
Products named: Xhale Spo2 Alar Fast
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Element Materials Technology $20,790
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.